Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 5.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 5.
DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER vs DEXTROSE 5%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides glucose for cellular energy metabolism. Lactated Ringer's solution replaces extracellular fluid and electrolytes. Lactate is metabolized to bicarbonate in the liver, providing buffering capacity for metabolic acidosis.
Dextrose 5% provides a source of calories and water for intravenous administration. It is metabolized to carbon dioxide and water, yielding energy. Dextrose solutions exert osmotic effects and can increase blood glucose levels.
Intravenous infusion; adult dose is 500-1000 mL per 24 hours, titrated to fluid and electrolyte needs.
Intravenous infusion; 5% dextrose in water (D5W) is typically administered at a rate of 100-200 mL/hour to provide 50-100 g of glucose per day for maintenance hydration and minimal caloric support in adults.
None Documented
None Documented
2–4 hours (intravenous). Clinical context: reflects glucose clearance; prolonged in renal impairment.
0.5-1 hour (endogenous glucose); intravenous infusion half-life is variable due to continuous cellular uptake and metabolism; clinical context: rapid clearance via insulin-mediated cellular uptake and glycolysis.
Renal: >99% as glucose. Biliary/fecal: negligible (<1%).
Renal: 100% (D-glucose and its metabolites, including CO2 and water); less than 1% excreted unchanged in urine under normal conditions; fecal excretion negligible.
Category C
Category C
IV Fluid
IV Fluid